A subgroup analysis showed that patients with MetS had higher levels of CRP compared to nonMetS patients and both groups of controls (4.96, 3.49–6.27 and 2.68, 1.95–4.63; p < 0.01 and p < 0.05; Table 5, Figure 1). The gene discussed is CRP; the disease is metabolic syndrome.